GURUFOCUS.COM » STOCK LIST » Oceania » Australia » ASX » Vectus Biosystems Ltd (ASX:VBS) » Definitions » YoY EBITDA Growth
Switch to:

Vectus Biosystems (ASX:VBS) YoY EBITDA Growth

: 36.62% (As of Dec. 2022)
View and export this data going back to 2016. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vectus Biosystems's YoY EBITDA Growth for the quarter that ended in Dec. 2022 was 36.62%.

Vectus Biosystems's EBITDA per Share for the six months ended in Dec. 2022 was A$-0.05.

Vectus Biosystems YoY EBITDA Growth Historical Data

The historical data trend for Vectus Biosystems's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
YoY EBITDA Growth
Premium Member Only Premium Member Only 17.07 40.59 -10.89 -17.86 25.76

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
YoY EBITDA Growth Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.92 -10.00 -7.58 56.06 36.62

Vectus Biosystems YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vectus Biosystems's YoY EBITDA Growth for the fiscal year that ended in Jun. 2022 is calculated as:

YoY EBITDA Growth (A: Jun. 2022 )
=(EBITDA per Share (A: Jun. 2022 )-EBITDA per Share (A: Jun. 2021 ))/ | EBITDA per Share (A: Jun. 2021 ) |
=(-0.098--0.132)/ | -0.132 |
=25.76 %

Vectus Biosystems's YoY EBITDA Growth for the quarter that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (Q: Dec. 2022 )
=(EBITDA per Share (Q: Dec. 2022 )-EBITDA per Share (Q: Dec. 2021 )) / | EBITDA per Share (Q: Dec. 2021 )) |
=(-0.045--0.071)/ | -0.071 |
=36.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectus Biosystems YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Vectus Biosystems logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » YoY EBITDA Growth
Comparable Companies
ASX:PAB ASX:DXB ASX:IXC ASX:ATH ASX:HXL ASX:CHM ASX:AGN ASX:AVE ASX:MEM ASX:NSB OCSE:NOVO B ASX:CSL NAS:REGN NAS:VRTX NAS:MRNA XKRX:207940 NAS:BNTX HKSE:02269 NAS:SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Website
http://www.vectusbiosystems.com.au
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines